- Home
- DAWN vs OEC Comparison
DAWN vs OEC Comparison
Compare DAWN & OEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- OEC
- Stock Information
- Founded
- DAWN 2018
- OEC 1862
- Country
- DAWN United States
- OEC Luxembourg
- Employees
- DAWN N/A
- OEC N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- OEC Major Chemicals
- Sector
- DAWN Health Care
- OEC Industrials
- Exchange
- DAWN Nasdaq
- OEC Nasdaq
- Market Cap
- DAWN 624.8M
- OEC 592.4M
- IPO Year
- DAWN 2021
- OEC 2014
- Fundamental
- Price
- DAWN $7.47
- OEC $6.12
- Analyst Decision
- DAWN Strong Buy
- OEC Hold
- Analyst Count
- DAWN 7
- OEC 3
- Target Price
- DAWN $27.86
- OEC $10.00
- AVG Volume (30 Days)
- DAWN 1.5M
- OEC 701.6K
- Earning Date
- DAWN 10-30-2025
- OEC 11-04-2025
- Dividend Yield
- DAWN N/A
- OEC 1.34%
- EPS Growth
- DAWN N/A
- OEC N/A
- EPS
- DAWN N/A
- OEC 0.26
- Revenue
- DAWN $187,638,000.00
- OEC $1,841,700,000.00
- Revenue This Year
- DAWN $12.96
- OEC N/A
- Revenue Next Year
- DAWN $48.40
- OEC $3.32
- P/E Ratio
- DAWN N/A
- OEC $23.55
- Revenue Growth
- DAWN 2190.50
- OEC N/A
- 52 Week Low
- DAWN $5.64
- OEC $5.23
- 52 Week High
- DAWN $16.76
- OEC $19.48
- Technical
- Relative Strength Index (RSI)
- DAWN 53.82
- OEC 27.42
- Support Level
- DAWN $6.99
- OEC $5.23
- Resistance Level
- DAWN $7.73
- OEC $7.33
- Average True Range (ATR)
- DAWN 0.44
- OEC 0.31
- MACD
- DAWN 0.02
- OEC -0.05
- Stochastic Oscillator
- DAWN 48.73
- OEC 32.19
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About OEC Orion S.A.
Orion SA is a manufacturer of carbon black products. Carbon black is a powdered form of carbon used to create the desired physical, electrical and optical qualities of various materials. The company's operating segments are Specialty Carbon Black and Rubber Carbon Black. It generates maximum revenue from the Rubber Carbon Black segment. Rubber Carbon Black segment is used in the reinforcement of rubber in tires and mechanical rubber goods. The Specialty Carbon Black segment is used as pigments and performance additives in coatings, polymers, printing and special applications. Geographically, it derives a majority of its revenue from Germany.